rs4426527

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_000030.3(AGXT):​c.1020A>G​(p.Ile340Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.189 in 1,613,084 control chromosomes in the GnomAD database, including 30,860 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I340T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.15 ( 2129 hom., cov: 33)
Exomes 𝑓: 0.19 ( 28731 hom. )

Consequence

AGXT
NM_000030.3 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:11O:1

Conservation

PhyloP100: 2.93

Publications

65 publications found
Variant links:
Genes affected
AGXT (HGNC:341): (alanine--glyoxylate aminotransferase) This gene is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targetting, have been associated with type I primary hyperoxaluria. [provided by RefSeq, Jul 2008]
AGXT Gene-Disease associations (from GenCC):
  • alanine glyoxylate aminotransferase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • primary hyperoxaluria type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Myriad Women’s Health, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 130 curated pathogenic missense variants (we use a threshold of 10). The gene has 12 curated benign missense variants. Gene score misZ: -0.26789 (below the threshold of 3.09). Trascript score misZ: -0.48778 (below the threshold of 3.09). GenCC associations: The gene is linked to alanine glyoxylate aminotransferase deficiency, primary hyperoxaluria type 1.
BP4
Computational evidence support a benign effect (MetaRNN=0.0022816956).
BP6
Variant 2-240878099-A-G is Benign according to our data. Variant chr2-240878099-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 39486.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.201 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGXTNM_000030.3 linkc.1020A>G p.Ile340Met missense_variant Exon 10 of 11 ENST00000307503.4 NP_000021.1 P21549

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGXTENST00000307503.4 linkc.1020A>G p.Ile340Met missense_variant Exon 10 of 11 1 NM_000030.3 ENSP00000302620.3 P21549
AGXTENST00000470255.1 linkn.798A>G non_coding_transcript_exon_variant Exon 2 of 3 2

Frequencies

GnomAD3 genomes
AF:
0.153
AC:
23240
AN:
152056
Hom.:
2127
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0618
Gnomad AMI
AF:
0.248
Gnomad AMR
AF:
0.136
Gnomad ASJ
AF:
0.189
Gnomad EAS
AF:
0.0751
Gnomad SAS
AF:
0.104
Gnomad FIN
AF:
0.242
Gnomad MID
AF:
0.187
Gnomad NFE
AF:
0.204
Gnomad OTH
AF:
0.167
GnomAD2 exomes
AF:
0.164
AC:
41095
AN:
250624
AF XY:
0.166
show subpopulations
Gnomad AFR exome
AF:
0.0629
Gnomad AMR exome
AF:
0.106
Gnomad ASJ exome
AF:
0.196
Gnomad EAS exome
AF:
0.0857
Gnomad FIN exome
AF:
0.250
Gnomad NFE exome
AF:
0.206
Gnomad OTH exome
AF:
0.180
GnomAD4 exome
AF:
0.193
AC:
281700
AN:
1460910
Hom.:
28731
Cov.:
34
AF XY:
0.190
AC XY:
138282
AN XY:
726764
show subpopulations
African (AFR)
AF:
0.0617
AC:
2066
AN:
33480
American (AMR)
AF:
0.107
AC:
4806
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.193
AC:
5043
AN:
26128
East Asian (EAS)
AF:
0.0777
AC:
3086
AN:
39700
South Asian (SAS)
AF:
0.106
AC:
9137
AN:
86256
European-Finnish (FIN)
AF:
0.244
AC:
12847
AN:
52604
Middle Eastern (MID)
AF:
0.171
AC:
989
AN:
5768
European-Non Finnish (NFE)
AF:
0.210
AC:
232950
AN:
1111876
Other (OTH)
AF:
0.178
AC:
10776
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
12981
25962
38944
51925
64906
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7960
15920
23880
31840
39800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.153
AC:
23245
AN:
152174
Hom.:
2129
Cov.:
33
AF XY:
0.152
AC XY:
11317
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.0619
AC:
2571
AN:
41552
American (AMR)
AF:
0.136
AC:
2081
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.189
AC:
657
AN:
3468
East Asian (EAS)
AF:
0.0751
AC:
388
AN:
5168
South Asian (SAS)
AF:
0.105
AC:
504
AN:
4822
European-Finnish (FIN)
AF:
0.242
AC:
2565
AN:
10580
Middle Eastern (MID)
AF:
0.184
AC:
54
AN:
294
European-Non Finnish (NFE)
AF:
0.204
AC:
13851
AN:
67970
Other (OTH)
AF:
0.165
AC:
348
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1005
2010
3016
4021
5026
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
260
520
780
1040
1300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.183
Hom.:
8117
Bravo
AF:
0.143
TwinsUK
AF:
0.214
AC:
793
ALSPAC
AF:
0.204
AC:
786
ESP6500AA
AF:
0.0640
AC:
282
ESP6500EA
AF:
0.208
AC:
1788
ExAC
AF:
0.164
AC:
19922
Asia WGS
AF:
0.0730
AC:
254
AN:
3478
EpiCase
AF:
0.206
EpiControl
AF:
0.202

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:11Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary hyperoxaluria, type I Uncertain:1Benign:6Other:1
Nov 17, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 01, 2004
OMIM
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:literature only

- -

-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Nov 27, 2014
Clinical Biochemistry Laboratory, Health Services Laboratory
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:in vitro

- -

Oct 30, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 1703535, 33457257, 24205397, 30341509, 28906061, 15802217) -

not specified Benign:2
Jun 26, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.053
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
0.50
DANN
Benign
0.091
DEOGEN2
Benign
0.26
T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.049
N
LIST_S2
Benign
0.23
T
MetaRNN
Benign
0.0023
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-2.2
N
PhyloP100
2.9
PrimateAI
Benign
0.40
T
PROVEAN
Benign
3.2
N
REVEL
Benign
0.27
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.054
MPC
0.033
ClinPred
0.0076
T
GERP RS
2.2
Varity_R
0.32
gMVP
0.76
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4426527; hg19: chr2-241817516; COSMIC: COSV56753667; COSMIC: COSV56753667; API